All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YC0188 | Human anti-C26H52NO7P T cell receptor (BK6), pCDTCR1 | BK6 | Human | 1-O-oleoyl-sn-glycero-3-phosphocholine | human CD1a | Lentiviral vector | ||
TCR-YC0189 | Human anti-C26H52NO7P T cell receptor (J24.L17), pCDTCR1 | J24.L17 | Human | 1-elaidoyl-sn-glycero-3-phosphocholine | human CD1d | Lentiviral vector | ||
TCR-YC0190 | Human anti-C26H52NO7P T cell receptor (YC03), pCDTCR1 | YC03 | Human | 1-oleoyl-2-hydroxy-sn-glycero-3-phosphocholine | human CD1d | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION